Johnson and Johnson
2025–2026 federal contribution records · FEC Schedule A
Overview
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Reported employer · contributions by individuals who listed this employer, not by the company · Industry: Healthcare & Pharmaceuticals · FEC Schedule ASearch FEC records
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
These are the last published financial totals; newer source data is not included yet.
Party shares are as of the party graph published ; a newer graph is being applied, and the totals are unchanged.
Across this cycle, 9,396,744 contributions come from electronic filings the FEC has not yet processed into its bulk data; those rows are replaced by the FEC version when it does.
Party totals describe recipients, not the contributors’ party registration or beliefs. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities.
Loading company overview…
Loading monthly totals…
These immutable labels appeared in FEC filings and are grouped under Johnson and Johnson.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported contributor groups, with evidence-based name-variant matching; not verified unique people.
Where the contributions went.
Explore the reported connections for Johnson & Johnson. Contributor and recipient lists are available below.
Party labels and allocations are as of the party graph published ; a newer graph is being applied.
Reported as Johnson and Johnson
Industry classification summary
Johnson & Johnson (J&J) is a global pharmaceutical, biotechnology, and medical technologies corporation. While it formerly had a consumer health division, the research indicates its current primary operations are divided into Innovative Medicine and MedTech, making Healthcare & Pharmaceuticals the correct sector classification.
AI-generated classification based on saved sources
View source| Month | Given |
|---|---|
| Jan 25 | $5,536 |
| Feb 25 | $22,026 |
| Mar 25 | $50,601 |
| Apr 25 | $26,586 |
| May 25 | $11,537 |
| Jun 25 | $29,960 |
| Jul 25 | $21,241 |
| Aug 25 | $16,336 |
| Sep 25 | $14,970 |
| Oct 25 | $25,781 |
| Nov 25 | $19,406 |
| Dec 25 | $17,309 |
| Jan 26 | $14,011 |
| Feb 26 | $14,547 |
| Mar 26 | $27,598 |
| Apr 26 | $15,829 |
| May 26 | $29,115 |
| Jun 26 | $17,816 |
| Jul 26 | $23,192 |
| Aug 26 | $18,746 |
| Sep 26 | $9,534 |
Current amendment versions from the published contribution data; memo entries are excluded.